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Abstract
Purpose Although rare, children and young adults can
suffer from significant cardiac arrhythmia, especially in
the context of congenital malformations and after cardiac
surgery.
Methods A total of 62 patients (32 female, median age
20 years) underwent an invasive electrophysiology study
between 2008–2011: half had normal cardiac anatomy,
whereas the remaining patients had various types of
congenital heart disease. All patients were treated using
either conventional techniques (CVN) or remote magnetic
navigation (RMN).
Results Patients treated with the RMN system differed sub-
stantially from patients in the CVN group with respect to
presence of congenital heart disease (67 % vs. 37 %), pre-
vious cardiac surgery (59 % vs. 20 %) or failed previous
conventional ablation (22 % vs. 9 %), respectively. Al-
though these more complex arrhythmias resulted in longer
median procedure duration (180 vs. 130 min, p=0.034), the
median overall fluoroscopy exposure in the RMN group was
significantly lower (4.1 vs. 5.2 min, p=0.020). Clinical out-
come was comparable in both groups without complications
caused by the ablation.
Conclusions Catheter ablation using remote magnetic navi-
gation is safe and feasible in children and young adults and
is especially valuable in patients with abnormal cardiac
morphologies. RMN resulted in significantly lower radia-
tion exposure compared with the conventional technique.
Keywords Catheter ablation . Cardiac arrhythmia . Young
adults . Remote magnetic navigation . Congenital heart
disease
Introduction
The prognosis of patients with congenital heart disease
(CHD) has improved in recent decades [1]. Congenital heart
surgery has made substantial progress so most of these
children now survive and have become a large heteroge-
neous group of young adults with corrected heart anatomy
[2–4]. Causative factors of arrhythmias in patients with
CHD are: complex anatomy, scar and surgical patch material
related re-entry [5, 6] accessory pathways, haemodynamic
differences and atrial or ventricular enlargement [7]. Al-
though the majority of patients with CHD and arrhythmias
are treated with antiarrhythmic drugs, ablation therapy is an
effective and curatively intended treatment option.
Especially in young patients it is very important to reduce
the amount of radiation from fluoroscopy during electro-
physiology procedures. These patients have a longer life
expectancy, are more susceptible to radiation and are more
likely to be exposed to more interventional procedures in the
future [8]. The risk of radiation effects and radiation-
induced cancer is significantly higher in young patients than
in adult patients [9]. Minimising the radiation dose will
reduce the late effects of radiation exposure [10, 11].
Precision and accurate navigation are essential to perform
successful ablations in CHD patients and children, which
can be achieved by using advanced technologies such as 3D
electroanatomical mapping systems [12], image integration
from CT or MRI and remote navigation by magnetic
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navigation [13]. We report on a single-operator experience
using various techniques including magnetic navigation to
treat symptomatic patients up to the age of 25 years.
Methods
Study design
This is an observational study of ablation procedures
performed at the Royal Brompton Hospital under the direct
or supervised care of a single consultant cardiologist (SE)
during the period from October 2007 until October 2011.
The data were exported from the local database (Lotus
Notes) by the Quality and Safety Office and analysed
retrospectively.
Patient cohort
A total of 63 patients were referred to the electrophysiology
(EP) department for ablation therapy because of symptom-
atic cardiac arrhythmias; one patient was excluded from
analysis because no arrhythmia was induced during EP
study. We included 62 patients who were not older than 25
at the date of the index ablation procedure. Treatment with
either conventional or remote magnetic navigation was
based on the type of arrhythmia and cardiovascular anato-
my. Patients with pacemakers were not excluded from the
remote magnetic navigation group.
Electrophysiology procedure
Before the ablation a resting 12-lead ECG and laboratory
tests were performed. Informed consent was obtained prior to
the procedure. The procedures were performed either under
local or general anaesthesia using intravenous sedation. The
blood pressure of the patients was continuously monitored
using radial or brachial arterial lines. Vascular access was
gained via the femoral veins and arteries or, if necessary, via
the subclavian or jugular veins. All patients underwent a post-
ablation transthoracic echocardiogram to exclude pericardial
effusion or damage to valvular structures.
Pre-ablation imaging
In the presence of CHD or when cardiac abnormalities were
suspected, the patients underwent a cardiac imaging study to
acquire a 3D cardiac roadmap for image integration into the
3D electroanatomical mapping system (CARTO, Biosense
Webster). Preference was given to a non-contrast cardiovas-
cular magnetic resonance (CMR), but in case of an
implanted device, a contrast cardiac computed tomography
(CT) was performed.
Conventional guided navigation
Conventional navigation (CVN) techniques are based on the
electrical information provided by multiple diagnostic cath-
eters and a manually steered ablation catheter. As an addi-
tional option, the electroanatomical mapping system
CARTO (Biosense Webster, Brussels Belgium) was used
when necessary [13].
Remote magnetic navigation
The remote magnetic navigation (RMN) system (Stereotaxis
Inc.) uses two permanent magnets to steer the magnetic tip
of a floppy ablation catheter. The operator is able to change the
directions of the magnetic field (0.08 Tesla) by changing the
orientation of the outer magnetic field. Using a mechanical
drive (Cardiodrive, Stereotaxis Inc) the magnetic catheter can
be pulled back or pushed forward, thereby allowing the oper-
ator to perform the procedure from inside the control room
[14]. The tip of the catheter is very soft and therefore is
unlikely to perforate or damage the vessel and heart walls.
Data collection and analysis
The data were analysed in subgroups based on navigation
techniques, presence of CHD, age and the specific arrhyth-
mia. The variables were chosen to describe the results and
effects of the ablations. Total procedure time, total fluoros-
copy time and radiofrequency (RF) time are presented as
median values and their first and third quartiles. Total pro-
cedure time was defined as the time in minutes from the
venous puncture to the removal of the catheter sheaths. The
acute success of the procedure was measured using pacing
protocols performed after ablation during the waiting time
period. If no tachycardia could be induced 30 minutes after
ablation, the procedure was acutely successful. Long-term
effects of the procedure were measured using follow-up
results from an outpatient clinic appointment: success was
defined as a sinus rhythm on ECG or 24-hour Holter and
symptom-free follow-up period of 6 months.
Statistics
The results were analysed using an intention-to-treat proto-
col. SPSS version 17.0 (SPSS Inc., Chicago, IL) was used to
perform statistical analysis. Qualitative variables were
presented as percentages and comparisons were done using
Pearson’s chi-squared test or Fisher’s exact test. Quantita-
tive variables were presented as mean (SD) or median (IQR)
and comparisons were done using the independent two-
sample Student’s t-test or the two-sample Wilcoxon rank-
sum test. A P-value of less than 0.05 was considered statis-
tically significant.
Neth Heart J (2013) 21:296–303 297
Results
Population (Table 1, Figs. 1 and 2)
The median age of all 62 patients undergoing invasive EP
procedures was 20 years (IQR: 18, 23) and 52 % were
female. Two patients were younger than 10 years, four
patients aged from 11–15 years, 26 patients aged from
16–20 years and 30 patients aged from 21–25 years.
Patients were treated in the index procedure using either
CVN (n=35 patients) or RMN (n=27 patients). CHD
was present in 31 patients and five patients had an
implanted pacemaker. More than one-third of the pa-
tients had undergone previous heart surgery for congen-
ital or structural heart disease. The cohort includes
patients after Mustard operation (n=3 patients) or an
atrial switch (n=3 patients) for transposition of the great
arteries, Fontan operation (n=6), Ebstein’s anomaly (n=8),
ventricular septal defect (n=4) or tetralogy of Fallot (n=4).
Nine patients had a failed previous CVN ablation in a different
hospital.
The median age of patients in the RMN subgroup (n=27)
was 21 years (18, 22) and the median age in the CVN subgroup
(n=35) was 20 (17, 23). There were statistically significantly
more patients with CHD (p=0.021) and previous cardiac sur-
gery (p=0.002) in the RMN group compared with the CVN
group. All patients’ baseline characteristics are listed in Table 1.
Procedure parameters: RMN versus CVN (Table 2, Fig. 3)
The median procedure time was significantly longer in the
RMN group compared with the CVN group, 180 min (133,
240) vs. 130 min (94.5, 192,5) respectively (p=0.034). The
median fluoroscopy time in the RMN group was statistically
significantly lower compared with the CVN group, 4.1 min
(1.5, 5.9) vs. 5.2 min (3.2, 11.1) respectively (p=0.020).
Both groups had similar median RF times and success rate.
CVN had no acute success in 3 patients with normal cardiac
anatomy: 1 patient with atrioventricular reentrant tachycardia
(AVRT), 1 patient with ventricular extrasystoles and 1 with
atrial tachycardia. The RMN group had no acute success in 1
patient with ventricular tachycardia after atrial switch surgery
Table 1 Patient demographics and RMN vs. CVN procedure results
Parameters All patients RMN CVN P Value
N 62 27 35 0.310
Median age (1–3 QR) 19.7 (3.9) 21 (18–22) 20 (17–23) 0.976
Gender: female (N, %) 32 (51.6 %) 15 (56 %) 17 (49 %) 0.585
Congenital HD (N, %) 31 (50 %) 18 (67 %) 13 (37 %) 0.021*
Implanted pacemaker (N, %) 5 (8.1 %) 4 (15 %) 1 (3 %) 0.086
Previous surgery (N, %) 23 (37 %) 16 (59 %) 7 (20 %) 0.002*
Previous ablation (N, %) 9 (14.5 %) 6 (22 %) 3 (9 %) 0.130
Atrial tachycardia (N, %) 14 (22.6 %) 6 (22 %) 8 (23 %) 0.953
AVRT (N, %) 22 (35.5 %) 6 (22 %) 16 (46 %) 0.055
AVNRT (N, %) 14 (22.6 %) 6 (22 %) 8 (23 %) 0.953
Ventricular extrasystoles (N, %) 5 (8.1 %) 4 (15 %) 1 (3 %) 0.086
Ventricular tachycardia (N, %) 4 (6.5 %) 3 (11 %) 1 (3 %) 0.190
Atrial fibrillation (N, %) 1 (1.6 %) 1 (4 %) 0 (0 %) 0.251
Atrial flutter (N, %) 2 (3.2 %) 1 (4 %) 1 (3 %) 0.852
Pre-abation imaging (N) 19 (31 %) 7 CMR, 5 CT 5 CMR, 2 CT 0.101
Total procedure time (min, 1–3 IQR) 152 (98, 214) 180 (133.0–240.0) 130 (94.5–192.5) 0.034*
Fluoroscopy time (min, 1–3 IQR) 4.25 (2.5, 10.2) 4.1 (1.5–5.85) 5.2 (3.2–11.1) 0.020*
RF time (min, 1–3 IQR) 10.4 (5.5, 18.4) 11.7 (7.5–23.5) 10.0 (4.7–13.6) 0.094
General anaesthesia (N, %) 35 (56.5 %) 18 (67 %) 17 (49 %) 0.154
Acute success 91.9 % 93 % 91 % 0.867
Arrhythmia-free follow-up 67 % 65 % 69 % 0.765
Table with the demographics of the patient population and the procedure results in the remote magnetic navigation (RMN) and conventional
navigation (CVN) group. The p-values show the differences between the two groups. Congenital HD: congenital heart disease; previous surgery:
previous heart surgery for congenital or structural heart disease; AVRT atrioventricular reentrant tachycardia, AVNRT atrioventricular nodal reentrant
tachycardia, CMR cardiac magnetic resonance imaging, CT computed tomography scan, IQR interquartile range; min: minutes, RF radiofrequency;
acute success: successful procedure; follow-up: percentage free of arrhythmia
* Statistically significant
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for transposition of the great arteries and 1 patient with normal
cardiac anatomy and AVRT. After six-month follow-up there
was no difference in arrhythmia-free patients between the
RMN and the CVN group (65 % vs 69 % p=0.765).
RMN versus CVN: Congenital heart disease subgroup
(Table 2, Fig. 4)
The subgroup analysis of CHD patients compared the pa-
tients treated with RMN (n=18) and the patients treated with
CVN (n=13) techniques. The CVN group consisted of
significantly more Ebstein’s anomaly patients (6 versus 2
patients, p=0.028) and patients with AVRT (1 versus 5
patients, p=0.022). Previous cardiac surgery for CHD was
present in 89 % of the patient treated with RMN, a signif-
icant difference compared with the CVN group (p=0.030).
There was no significant difference in procedure and fluo-
roscopy time between the groups. The median procedure
time in the RMN group was 186 min (154, 264) and the
median procedure time in the CVN group was 203 min
(130, 223). The median fluoroscopy time was 3.7 min
(2.3, 6.2) compared with 4.1 min (3.3, 11.0) in the CVN
group. Both groups had similar acute success rates and
comparable six-month follow-up results.
Fig. 1 Age distribution. Pie
chart of the age distribution of
both patient groups: Left panel
depicts the conventionally
treated group (CNV), while the
right panel shows the remote
magnetic navigation (RMN)
cohort
Fig. 2 Flowchart of all ablation procedures. Flowchart of all 72 pro-
cedures in a total of 62 patients, with the majority (N=55) having only
one procedure. Four patients had a second procedure and 3 patients had a
second and a third procedure. Abbreviations: RMN: remote magnetic
navigation. CVN: conventional navigation, Ebstein: Ebstein’s anomaly,
Fontan: Fontan-like circulation, NA: normal cardiac anatomy, cTGA:
corrected transposition of the arteries, CHD: congenital heart disease,
AT: atrial tachycardia, AVRT atrioventricular reentrant tachycardia,
AVNRT: atrioventricular nodal reentrant tachycardia, *: Congenital mitral
valve cleft with previous mitral valve repair and replacement, #: Posterior
pathway and an epicardial located accessory pathway, ^: Left posterior
lateral accessory pathway
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Table 2 Procedure results in
congenital heart disease: RMN
vs. CVN
Table with the procedure results
of the subgroup analysis of
patients with congenital heart
disease. SD standard deviation,





magnetic resonance imaging, CT
computed tomography scan;




Parameters RMN CVN P-value
N 18 13 0.369
Ebstein’s anomaly (N, %) 2 (11 %) 6 (46 %) 0.028*
Tetralogy of Fallot (N, %) 2 (11 %) 2 (15 %) 0.726
Corrected TGA (N, %) 5 (28 %) 1 (8 %) 0.164
Post Fontan procedure (N, %) 4 (22 %) 2 (15 %) 0.634
Ventricular septal defect (N, %) 2 (11 %) 2 (15 %) 0.726
Previous cardiac surgery (N, %) 16 (89 %) 7 (54 %) 0.030*
Previous ablation (N, %) 5 (28 %) 2 (15 %) 0.423
Targeted arrhythmia
Atrial tachycardia (N, %) 6 (33 %) 7 (54 %) 0.253
Ventricular tachycardia (N, %) 3 (17 %) 1 (8 %) 0.462
Ventricular extrasystoles (N, %) 4 (22 %) 0 (0 %) 0.069
AVNRT (N, %) 2 (11 %) 0 (0 %) 0.214
AVRT (N, %) 1 (6 %) 5 (38 %) 0.022*
Atrial fibrillation (N, %) 1 (6 %) 0 (0 %) 0.388
Atrial flutter (N, %) 1 (6 %) 0 (0 %) 0.388
Procedure parameters
General anaesthesia (N, %) 15 (83 %) 10 (77 %) 0.661
Pre-ablation imaging (N) 6 CMR, 3 CT 1 CMR 0.453
Median procedure time (min, 1–3 IQR) 186 (154, 264) 203 (130, 223) 0.674
Median fluoroscopy time (min, 1–3 IQR) 3.7 (2.3, 6.2) 4.1 (3.3, 11) 0.123
Median radiofrequency time (min, 1–3 IQR) 18.2 (9.4, 24.6) 12.2 (11, 22.4) 0.603
Acute success 94 % 100 % 0.395
Arrhythmia-free follow-up 67 % 62 % 0.873
Redo ablation (N,%) 4 (22 %) 1 (8 %) 0.286
Fig. 3 Boxplot comparison of
RMN vs. CVN. Comparison of
procedure duration and overall
fluoroscopy exposure times
during the index procedure for
all patients
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Complications
Post-ablation transthoracic echocardiography showed no
pericardial effusion, tamponade or damage to the aorta and
mitral valve. There were no other major complications,
except for one patient, who developed a haemothorax after
positioning of a central jugular venous catheter used for
anaesthesia.
Discussion
The results of our retrospective study show that catheter
ablation of arrhythmias in children and young adults is
effective and safe. RMV is highly effective even in young
patients and even in the presence of CHD. In the context of
these young and more complex patients, they are more likely
to relapse into tachycardia in the future [2]. Triedman et al.
report a recurrence rate of atrial tachycardia of 53 % in CHD
patients after 3 years [15]. In our cohort, only 11.3 % of the
patients needed a redo ablation, which seems acceptable
regarding the type of patients included in this study. To
summarise, these young CHD patients have more complex
tachycardia substrates, a higher risk for redo ablation, a higher
radiation exposure and a lower success rate of ablation.
Remote navigation versus conventional ablation techniques
There are only few reports in the literature about catheter
ablations with RMN in children and young adults [15, 16].
However the RMN system has the advantage of the floppy and
soft catheter tip that is less likely to perforate the thin wall of
the heart or blood vessel. The RMN system has been previ-
ously demonstrated to be effective in the treatment of cardiac
arrhythmias in an adult CHD patient population [16, 17].
Reduction of radiation exposure in children and young adults
It is essential to reduce radiation exposure in general as much
as possible [18]. The short- and late-term effects of fluoros-
copy exposure are more distinct in children and young adults
[8]. The overall fluoroscopy exposure during catheter ablation
is generally higher in CHD patients [2, 16]. The RMN system
has been reported to significantly reduce fluoroscopy expo-
sure during catheter ablation in various patient cohorts.
[19–21] Although we managed to successfully treat patients
in our conventional group with very low exposure to radiation
as compared with previously published reports [16, 17, 22],
we could still demonstrate a significant reduction in exposure
when using magnetic navigation although those patients were
more complex to treat. The effect of reduction of radiation
exposure by using remote navigation has been previously
reported by other groups [23, 24] for normal morphology
patients and also for CHD patients or young patients
[16, 25]. The significant reduction in radiation exposure
by using RMN in our study is similar compared with
that of Schwagten et al. [16, 17], but the total fluoroscopy
exposure in our CVN group was already lower than
their RMN group. This absolute difference in procedure
and fluoroscopy time could be potentially explained by the
more extensive use of image integration and 3D mapping
in our study.
Fig. 4 Boxplot comparison of
RMN vs. CVN in congenital
heart disease. Comparison of
procedure duration and overall
fluoroscopy exposure times
during the index procedure for
all patients with congenital
heart disease (CHD)
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Limitation in vascular access in paediatric patients
Our cohort mainly consisted of adolescents and young
adults, while only about 10 % of patients were under
the age of 15 years. This is mainly due to the local
referral basis, but also reflects on the obvious limitations to
vascular access in younger children. The diameter of the
available ablation catheters for the RMN system is
currently limited to 7 French; however, in the conventional
group no 6 French catheters were used. This could impose a
limitation for using remote navigation in even younger
children.
Complications
During ablation procedures in adults the overall compli-
cation risk is 3.8 %, with a risk for cardiac perforation
of 1.3 % [26]. In our study, we had a comparably lower
complication rate, with only one case of a haemothorax
(1.6 %).
Limitations
Considering the heterogeneity of CHD and arrhythmia
substrates and the small numbers in the specific arrhyth-
mia groups, all the subgroup analyses performed are
difficult to interpret and we have therefore limited this
to the presence of CHD. A multicentre prospective
randomised clinical trial would be needed to obtain
more reliable data about success and complication rates
of catheter ablation in children and young adults using
advanced technology.
Conclusion
Catheter ablation using remote magnetic navigation is safe
and feasible in children and young adults. In comparison to
a conventionally treated similar group of patients by the
same operator, RMN significantly lowered fluoroscopy ex-
posure. The use of advanced technology including integra-
tion of pre-acquired 3D imaging and 3D electro-anatomical
mapping was especially valuable in patients with complex
congenital heart disease.
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